AR110283A1 - Dinucleótido cíclico - Google Patents
Dinucleótido cíclicoInfo
- Publication number
- AR110283A1 AR110283A1 ARP170103344A ARP170103344A AR110283A1 AR 110283 A1 AR110283 A1 AR 110283A1 AR P170103344 A ARP170103344 A AR P170103344A AR P170103344 A ARP170103344 A AR P170103344A AR 110283 A1 AR110283 A1 AR 110283A1
- Authority
- AR
- Argentina
- Prior art keywords
- independently
- formula
- atom
- substituent
- compound
- Prior art date
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000004434 sulfur atom Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 206010003402 Arthropod sting Diseases 0.000 abstract 1
- 208000003014 Bites and Stings Diseases 0.000 abstract 1
- 229940044665 STING agonist Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016234553 | 2016-12-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR110283A1 true AR110283A1 (es) | 2019-03-13 |
Family
ID=62565132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170103344A AR110283A1 (es) | 2016-12-01 | 2017-11-30 | Dinucleótido cíclico |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP2018090562A (zh) |
| AR (1) | AR110283A1 (zh) |
| TW (1) | TWI769195B (zh) |
| UY (1) | UY37502A (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20170192A1 (ar) * | 2016-12-01 | 2019-01-30 | Takeda Pharmaceuticals Co | داي نوكليوتيد حلقي |
| AU2019337051B2 (en) * | 2018-09-06 | 2023-11-23 | Daiichi Sankyo Company, Limited | Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof |
| CN110511259B (zh) * | 2019-08-22 | 2022-08-16 | 陕西师范大学 | 环二核苷酸人工金属酶及其制备和催化不对称Friedel-Crafts反应的应用 |
| WO2022220019A1 (ja) * | 2021-04-16 | 2022-10-20 | 国立大学法人東京工業大学 | 非天然塩基を利用した長鎖ｄｎａ合成 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840533B2 (en) * | 2013-04-29 | 2017-12-12 | Memorial Sloan Kettering Cancer Center | Compositions and methods for altering second messenger signaling |
| MX354057B (es) * | 2013-05-18 | 2018-02-09 | The Regents Of The Univ Of California Star | Composiciones y métodos para activar la señalización dependiente del "estimulador del gene de interferón". |
| WO2016096174A1 (en) * | 2014-12-16 | 2016-06-23 | Invivogen | Fluorinated cyclic dinucleotides for cytokine induction |
| JP6692826B2 (ja) * | 2015-03-10 | 2020-05-13 | アドゥロ バイオテック，インク． | 「インターフェロン遺伝子刺激因子」依存性シグナル伝達の活性化のための組成物及び方法 |
| UA123701C2 (uk) * | 2015-08-13 | 2021-05-19 | Мерк Шарп І Доум Корп. | Циклічні динуклеотидні сполуки як агоністи sting |
| KR20180066241A (ko) * | 2015-10-28 | 2018-06-18 | 아두로 바이오테크, 인코포레이티드 | “인터페론 유전자의 자극제”-의존성 신호전달을 활성화시키기 위한 조성물 및 방법 |
| WO2017161349A1 (en) * | 2016-03-18 | 2017-09-21 | Immune Sensor, Llc | Cyclic di-nucleotide compounds and methods of use |
-
2017
- 2017-05-30 JP JP2017107216A patent/JP2018090562A/ja active Pending
- 2017-11-30 AR ARP170103344A patent/AR110283A1/es unknown
- 2017-11-30 TW TW106141865A patent/TWI769195B/zh active
- 2017-11-30 UY UY0001037502A patent/UY37502A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI769195B (zh) | 2022-07-01 |
| UY37502A (es) | 2018-06-29 |
| TW201825509A (zh) | 2018-07-16 |
| JP2018090562A (ja) | 2018-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019007032A2 (es) | Dinucleótido cíclico como agonistas de sting (estimulador de genes de interferón) | |
| AR128490A2 (es) | Compuesto derivado de carboxamida para el control de endoparásitos | |
| AR110283A1 (es) | Dinucleótido cíclico | |
| AR126406A2 (es) | Compuestos de tetrazolinona y su uso | |
| CR20160478A (es) | Composición de control de enfermedades de plantas y método para controlar enfermedades de plantas mediante su aplicación | |
| CO2017001178A2 (es) | Derivado de piridona que tiene un grupo tetrahidropiranil metilo | |
| AR095326A1 (es) | Heterociclos tricíclicos como inhibidores de la proteína bet | |
| AR103546A1 (es) | Compuestos de bipiridina y su uso para controlar artrópodos dañinos | |
| AR109905A1 (es) | Pirrolidinas sustituidas como moduladores de cftr | |
| ECSP15035343A (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida útiles como inhibidores de quinasa pim | |
| AR096837A1 (es) | Heterociclos tricíclicos como inhibidores de proteínas bet | |
| AR097633A1 (es) | Pesticidas de azol bicíclico sustituido con heterociclos | |
| ECSP19030134A (es) | Compuesto de piridina | |
| CO6300846A2 (es) | Derivados heterociclicos que contienen azufre que tienen actividad inhibitoria de la beta secretasa | |
| JO3706B1 (ar) | مشتقات H4- بيرولو[2,3-c] بيريدين-4- ون | |
| MX374452B (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
| ECSP17021897A (es) | Compuestos y composiciones como inhibidores de quinasa raf | |
| AR094876A1 (es) | Derivados de ácido betulínico modificados con alquilo c-3 y alquenilo | |
| BR112015024530A8 (pt) | compostos derivados de naftiridina úteis como antagonistas de integrina alfa-v-beta-6, composição farmacêutica, e, uso de um composto | |
| ECSP15019323A (es) | Derivados de 5-fluoro-n-(piridin-2-il)piridin-2-amina que contienen un grupo sulfoximina | |
| AR094966A1 (es) | Composiciones farmacéuticas para el tratamiento de infecciones hcv | |
| AR097866A1 (es) | Derivados de 4-azaindol | |
| AR082914A1 (es) | Heteroarilmetilamidas utiles para tratar enfermedades cardiovasculares y dislipemias, composiciones farmaceuticas que las contienen y proceso de preparacion de los mismos | |
| AR100879A1 (es) | Derivados de la indolizina como inhibidores de las fosfoinositido-3 quinasas | |
| AR098492A1 (es) | Derivados de purina |